CliniMACS CD34 Reagent System
HDE Number: BH110018
Device Name: CliniMACS CD34 Reagent System
Manufacturer: Miltenyi Biotech, Inc.
Indication:
- The CliniMACS CD34 Reagent System is indicated for processing hematopoietic progenitor cells collected by apheresis (HPC, Apheresis) from an allogeneic, HLA-identical, sibling donor to obtain a CD34+ cell-enriched population for hematopoietic reconstitution following a myeloablative preparative regimen without the need for additional graft versus host disease (GVHD) prophylaxis in patients with acute myeloid leukemia (AML) in first morphologic complete remission.